Ectopic T-bet expression licenses dendritic cells for IL-12-independent priming of type 1 T cells in vitro

Journal of Immunology

Volumn 183, Issue 11, 2009, Pages 7250-7258

  Lipscomb, Michael W ^a   Chen, Lu ^a   Taylor, Jennifer L ^a   Goldbach, Christina ^a   Watkins, Simon C ^a   Kalinski, Pawel ^a,b   Butterfield, Lisa H ^a,b   Wesa, Amy K ^a   Storkus, Walter J ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR BETA2; INTERLEUKIN 12P70; INTERLEUKIN 23; INTERLEUKIN 27; STAPHYLOCOCCUS ENTEROTOXIN B; TRANSCRIPTION FACTOR T BET; CYTOKINE; T BOX TRANSCRIPTION FACTOR; T BOX TRANSCRIPTION FACTOR TBX21; T-BOX TRANSCRIPTION FACTOR TBX21;

ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; ECTOPIC TISSUE; EFFECTOR CELL; GENETIC ENGINEERING; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; MEMORY CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TH1 CELL; TH2 CELL; BIOSYNTHESIS; CELL COMMUNICATION; CELL DIFFERENTIATION; CYTOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL COMMUNICATION; CELL DIFFERENTIATION; CYTOKINES; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-12; LYMPHOCYTE ACTIVATION; MICROSCOPY, FLUORESCENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-BOX DOMAIN PROTEINS; TH1 CELLS;

EID: 73349101422     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901477     Document Type: Article

References (55)

1. Rossi, M., and Young, J. W. 2005. Human dendritic cells: potent antigen-presenting cells at the crossroads of innate and adaptive immunity. J. Immunol. 175: 1373-1381. (Pubitemid 41023036)
2. Heath, W. R., G. T. Belz, G. M. N. Behrens, C. M. Smith, S. P. Forehan, I. A. Parish, G. M. Davey, N. S. Wilson, F. R. Carbone, and J. A. Villadangos. 2004. Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol. Rev. 199: 9-26. (Pubitemid 38736761)
3. Lucas, M., W. Schachterle, K. Oberle, P. Aichele, and A. Diefenbach. 2007. Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 26: 503-517. (Pubitemid 46602996)
4. Kapsenberg, M. L. 2003. Dendritic-cell control of pathogen-driven T-cell polarization. Nat. Rev. Immunol. 3: 984-993.
5. high regulatory T cells by human dendritic cells in vitro and after injection of cytokine-matured DCs in myeloma patients. Blood 108: 2655-2661.
6. van Beelen, A. J., Z. Zelinkova, E. W. Taanman-Kueter, F. J. Muller, D. W. Hommes, S. A. J. Zaat, M. L. Kapsenberg, and E. C. de Jong. 2007. Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. Immunity 27: 660-669.
7. Melief, C. J. M. 2008. Cancer immunotherapy by dendritic cells. Immunity 29: 372-383.
8. Hunter, C. A. 2005. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat. Rev. Immunol. 5: 521-531.
9. Fujii, S., K. Liu, C. Smith, A. J. Bonito, and R. M. Steinman. 2004. The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation. J. Exp. Med. 199: 1607-1618. (Pubitemid 38821994)
10. + T cells through STAT1-dependent and -independent mechanisms. Proc. Natl. Acad. Sci. USA 100: 15047-15052.
11. Watford, W. T., B. D. Hissong, J. H. Bream, Y. Kanno, L. Muul, and J. J. O'Shea. 2004. Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4. Immunol. Rev. 202: 139-156. (Pubitemid 39576910)
12. Skokos, D., and M. C. Nussenzweig. 2007. CD8- DCs induce IL-12-independent Th1 differentiation through δ4 notch-like ligand in response to bacterial LPS. J. Exp. Med. 204: 1525-1531. (Pubitemid 47048020)
13. + T cells to produce IFN-γ by an IL-12-independent but CD70-dependent mechanism in vivo.. J. Exp. Med. 204: 1095-1106.
14. Mullen, A. C., F. A. High, A. S. Hutchins, H. W. Lee, A. V. Villarino, D. M. Livingston, A. L. Kung, N. Cereb, T. P. Yao, S. Y. Yang, and S. L. Reiner. 2001. Role of T-bet in commitment of Th1 cells before IL-12-dependent selection. Science 292: 1907-1910.
15. Lighvani, A. A., D. M. Frucht, D. Jankovic, H. Yamane, J. Aliberti, B. D. Hissong, B. V. Nguyen, M. Gadina, A. Sher, W. E. Paul, and J. J. O'Shea. 2001. T-bet is rapidly induced by interferon-γ in lymphoid and myeloid cells. Proc. Natl. Acad. Sci. USA 98: 15137-15142.
16. + T cells. Nat. Immunol. 3: 549-557.
17. Finotto, S., M. F. Neurath, J. N. Glickman, S. Qin, H. A. Lehr, F. H. Y. Green, K. Ackerman, K. Haley, P. R. Galle, S. J. Szabo, et al. 2002. Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet. Science 295: 336-338. (Pubitemid 34074365)
18. Usui, T., J. C. Preiss, Y. Kanno, Z. J. Yao, J. H. Bream, J. J. O'Shea, and W. Strober. 2006. T-bet regulates Th1 responses through essential effects on GATA-3 function rather than on IFN-γ gene acetylation and transcription. J. Exp. Med. 203: 755-766.
19. Lametschwandtner, G., T. Biedermann, C. Schwärzler, C. Günther, J. Kund, S. Fassl, S. Hinteregger, N. Carballido-Perrig, S. J. Szabo, L. H. Glimcher, and J. M. Carballido. 2004. Sustained T-bet expression confers polarized human Th2 cells with Th1-like cytokine production and migratory capacities. J. Allergy Clin. Immunol. 113: 987-994.
20. Hwang, E. S., S. J. Szabo, P. L. Schwartzberg, and L. H. Glimcher. 2005. T helper cell fate specified by kinase-mediated interaction of T-bet with GATA-3. Science 307: 430-433.
21. Heckman, K. L., S. Radhakrishnan, T. Peikert, K. Iijima, H. C. McGregor, M. P. Bell, H. Kita, and L. R. Pease, LR. 2008. T-bet expression by dendritic cells is required for the repolarization of allergic airway inflammation. Eur. J. Immunol. 38: 2464-2474.
22. Lugo-Villarino, G., R. Maldonado-Lopez, R. Possemato, C. Penaranda, and L. H. Glimcher. 2003. T-bet is required for optimal production of IFN-γ and antigen-specific T cell activation by dendritic cells. Proc. Natl. Acad. Sci. USA 100: 7749-7754.
23. Lugo-Villarino, G., S. Ito, D. M. Klinman, and L. H. Glimcher. 2005. The adjuvant activity of CPG DNA requires T-bet expression in dendritic cells. Proc. Natl. Acad. Sci. USA 102: 13248-13253.
24. + T cell responses in vitro. J. Immunother. 30: 75-82.
25. Maillard, R. B., A. Wankowicz-Kalinska, Q. Cai, A. Wesa, C. M. Hilkens, M. L. Kapsenberg, J. M. Kirkwood, W. J. Storkus, and P. Kalinski. 2004. α-type-1 polarized dendritic cells: a novel immunization tool with optimized CTL-inducing activity. Cancer Res. 64: 5934-5937.
26. Li, H., W. Wojciechowski, C. Dell'Agnola, N. E. Lopez, and I. Espinoza-Delgado. 2006. IFN-γ and T-bet expression in human dendritic cells from normal donors and cancer patients is controlled through mechanisms involving ERK-1/2-dependent and IL-12-independent pathways. J. Immunol. 177: 3554-3563.
27. + T-cell responses from normal donors and melanoma patients in vitro. Cancer Gene Ther. 13: 798-805.
28. Butterfield, L. H., B. Comin-Anduix, L. Vujanovic, Y. Lee, V. B. Dissette, J. Q. Yang, H. T. Vu, E. Seja, D. K. Oseguera, D. M. Potter, et al. 2008. Adenovirus MART-1-engineered autologous dendritic cell vaccine for metastatic melanoma. J. Immunother. 31: 294-309.
29. van Kooten, C., and J. Banchereau. 2000. CD40-CD40 ligand. J. Leukocyte Biol. 67: 2-17.
30. Nestle, F. O., C. Thompson, Y. Shimizu, L. A. Turka, and B. J. Nickoloff. 1994. Costimulation of superantigen-activated T lymphocytes by autologous dendritic cells is dependent on B7. Cell. Immunol. 156: 220-229.
31. + T lymphocyte responses. Blood 96: 1857-1864.
32. + T-cell reactivity to the receptor tyrosine kinase EphA2 in patients with renal cell carcinoma. Cancer Res. 63: 4481-4489.
33. Kaufmann, D. E., P. M. Bailey, J. Sidney, B. Wagner, P. J. Norris, M. N. Johnston, L. A. Cosimi, M. M. Addo, M. Lichterfeld, M. Altfeld, et al. 2004. Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides. J. Virol. 78: 4463-4477.
34. Kalinski, P., A. Giermasz, Y. Nakamura, P. Basse, W. J. Storkus, J. M. Kirkwood, and R. B. Mailliard. 2005. Helper role of NK cells during the induction of anticancer responses by dendritic cells. Mol. Immunol. 42: 535-539.
35. Sallusto, F., J. Geginat, A. Lanzavecchia. 2004. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 22: 745-763.
36. + T cells. Eur. J. Immunol. 37: 129-138.
37. + T lymphocytes in human colorectal carcinoma. Int. J. Cancer 116: 949-956.
38. + T cells. Proc. Natl. Acad. Sci. USA 97: 400-405.
39. + NKT cells. Immunity 20: 477-494.
40. + T cell fate coupled by T-bet and eomesodermin. Nat. Immunol. 6: 1236-1244.
41. Sullivan, B. M., A. Juedes, S. J. Szabo, M. von Herrath, and L. H. Glimcher. 2003. Antigen-driven effector CD8 T cell function regulated by T-bet. Proc. Natl. Acad. Sci. USA 100: 15818-15823.
42. Yang, X. O., R. Nurieva, G. J. Martinez, H. S. Kang, Y. Chung, B. P. Pappu, B. Shah, S. H. Chang, K. S. Schluns, S. S. Watowich, et al. 2008. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 29: 44-56.
43. Awasthi, A., Y. Carrier, J. P. S. Peron, E. Bettelli, M. Kamanaka, R. A. Flavell, V. K. Kuchroo, M. Oukka, and H. L. Weiner. 2007. A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat. Immunol. 8: 1380-1389.
44. Zhou, L., I. I. Ivanov, R. Spolski, R. Min, K. Shenderov, T. Egawa, D. E. Levy, W. J. Leonard, and D. R. Littman. 2007. IL-6 programs Th-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 8: 967-974.
45. Amsen, D., J. M. Blander, G. R. Lee, K. Tanigaki, T. Honjo, and R. A. Flavell. 2004. Instruction of distinct CD4 T helper cell fates by different notch ligands on antigen-presenting cells. Cell 117: 515-526.
46. Reichardt, P., B. Dornbach, and M. Gunzer. 2007. The molecular makeup and function of regulatory and effector synapses. Immunol. Rev. 218: 165-177.
47. Liwski, R. S., J. C. Chase, W. H. Baldridge, I. Sadek, G. Rowden, and K. A. West. 2006. Prolonged costimulation is required for naive T cell activation. Immunol. Lett. 106: 135-143.
48. Iezzi, G., K. Karjalainen, and A. Lanzavecchia. 1998. The duration of antigenic stimulation determines the fate of naive and effector T cells. Immunity 8: 89-95.
49. Hurez, V., A. Saparov, A. Tousson, M. J. Fuller, T. Kubo, J. Oliver, B. T. Weaver, and C. T. Weaver. 2003. Restricted clonal expression of IL-2 by naive T cells reflects differential dynamic interactions with dendritic cells. J. Exp. Med. 198: 123-132. (Pubitemid 36870192)
50. + T cell activation. Immunity 27: 625-634.
51. + T cell repertoires specific for naturally processed antigens analyzed using libraries of amplified T cells. J. Exp. Med. 206: 1525-1534.
52. Vulink, A., K. J. Radford, C. Melief, and D. N. J. Hart. 2008. Dendritic cells in cancer immunotherapy. Adv. Cancer Res. 99: 363-407.
53. Ikeda, H., K. Chamoto, T. Tsuji, Y. Suzuki, D. Wakita, T. Takeshima, and T. Nishimura. 2004. The critical role of type 1 innate and acquired immunity in tumor immunotherapy. Cancer Sci. 95: 697-703.
54. Hishii, M., J. T. Kurnick, T. Ramirez-Montagut, and F. Pandolfi. 1999. Studies of the mechanism of cytolysis by tumour-infiltrating lymphocytes. Clin. Exp. Immunol. 116: 388-394.
55. Gao, Q., S. Qiu, J. Fan, J. Zhou, X. Wang, Y. Xiao, Y. Xu, Y. Li, and Z. Tang. 2007. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J. Clin. Oncol. 25: 2586-2593.